| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 28,453 | 39,243 | 53,167 | | Cost of Revenue | 2,289 | 2,438 | 2,826 | | | Gross Profit | 26,165 | 36,806 | 50,341 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 148 | 396 | 203 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 26,016 | 36,410 | 50,138 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (137,354) | (62,241) | (1,583) | | Earnings Before Interest And Taxes | 26,016 | 36,410 | 39,054 | | Interest Expense | 2,798 | 6,103 | 7,210 | | Income Before Tax | 23,219 | 30,307 | 31,844 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (114,136) | (31,934) | 41,345 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (114,136) | (31,934) | 41,345 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($114,136) | ($31,934) | $41,345 |
|
0.51% Nasdaq 
Income Statement
